What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Surgery
His scientific interests lie mostly in Internal medicine, Breast cancer, Surgery, Oncology and Cancer.
Roger A'Hern works in the field of Internal medicine, focusing on Chemotherapy in particular.
His studies in Breast cancer integrate themes in fields like Radiation dose and Computer tomographic.
His Surgery study combines topics in areas such as Multivariate analysis, Radiology and Sarcoma.
In his work, Germline mutation is strongly intertwined with Immunology, which is a subfield of Oncology.
His research investigates the connection between Cancer and topics such as Clinical trial that intersect with problems in Neuropathic pain, Anesthesia, Dermatology, Lidocaine and Systematic review.
His most cited work include:
- DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer. (1142 citations)
- Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group (1082 citations)
- Poly(ADP)-Ribose Polymerase Inhibition: Frequent Durable Responses in BRCA Carrier Ovarian Cancer Correlating With Platinum-Free Interval (749 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Internal medicine, Surgery, Breast cancer, Oncology and Chemotherapy.
His Internal medicine study incorporates themes from Gastroenterology, Endocrinology and Pathology.
His study looks at the relationship between Surgery and fields such as Carcinoma, as well as how they intersect with chemical problems.
As a member of one scientific family, Roger A'Hern mostly works in the field of Breast cancer, focusing on Cancer research and, on occasion, Apoptosis.
Roger A'Hern has researched Oncology in several fields, including Neutropenia, Clinical endpoint, Ovarian cancer, Disease and Survival analysis.
The various areas that Roger A'Hern examines in his Cancer study include Relative risk and Gynecology.
He most often published in these fields:
- Internal medicine (53.44%)
- Surgery (35.98%)
- Breast cancer (29.10%)
What were the highlights of his more recent work (between 2007-2019)?
- Internal medicine (53.44%)
- Breast cancer (29.10%)
- Oncology (29.10%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Internal medicine, Breast cancer, Oncology, Cancer and Endocrinology.
His Breast cancer research integrates issues from Molecular pathology and Gene expression profiling.
His study in Oncology is interdisciplinary in nature, drawing from both Neoadjuvant therapy, Clinical endpoint, Clinical trial, Chemotherapy and Biomarker.
His Chemotherapy research is classified as research in Surgery.
His work carried out in the field of Cancer brings together such families of science as Prospective cohort study and Pathology.
His studies deal with areas such as Aromatase and Estrogen receptor, GREB1 as well as Endocrinology.
Between 2007 and 2019, his most popular works were:
- DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer. (1142 citations)
- Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group (1082 citations)
- Poly(ADP)-Ribose Polymerase Inhibition: Frequent Durable Responses in BRCA Carrier Ovarian Cancer Correlating With Platinum-Free Interval (749 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Surgery
His primary areas of investigation include Internal medicine, Breast cancer, Cancer, Oncology and Prostate cancer.
Roger A'Hern studied Internal medicine and Endocrinology that intersect with Letrozole.
His study focuses on the intersection of Breast cancer and fields such as Molecular pathology with connections in the field of Gene expression profiling, Bioinformatics, Univariate analysis, Estrogen receptor and Chemotherapy.
His Cancer study deals with Gynecology intersecting with Residual risk, Biomarker, Clinical trial, Clinical research and Hormone therapy.
His Oncology study combines topics from a wide range of disciplines, such as Germline mutation, Ovarian cancer and Immunology.
The study incorporates disciplines such as Cancer research, Prostate, Cancer biomarkers and Pathology in addition to Prostate cancer.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
